MSB 4.69% $1.45 mesoblast limited

10 Sept 12pm NSW Stem Cell Network - Stem Cells vs COVID19, page-84

  1. 7,913 Posts.
    lightbulb Created with Sketch. 2082
    Also implied that even if Ryoncil is not approved by the FDA, Rem-L may still be approved for COVID ARDS if the trial is successful.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.